Acme United Reports 6% Sales Increase and 27% EPS Increase for First Quarter of 2023
Acme United Corporation (ACU) reported a strong first quarter for 2023, with net sales increasing by 6% to $45.8 million compared to $43.3 million in Q1 2022. Net income rose to $990,000 or $0.28 per diluted share, marking a 19% increase in net income and a 27% increase in earnings per share from last year. Despite some inventory reductions by large customers, the company noted significant productivity savings of over $0.5 million and projected annual savings of $5 million for 2023. However, there were declines in European sales by 6% and Canadian sales by 10%. The gross margin improved to 35.5%, attributed to cost-saving measures. Acme United also faced increased interest expenses due to higher rates, impacting financial performance.
- Net sales increased by 6% to $45.8 million in Q1 2023.
- Net income grew by 19% to $990,000, with diluted EPS up 27% to $0.28.
- Productivity savings exceeded $0.5 million in Q1 2023.
- Projected annual savings of $5 million for 2023.
- Gross margin improved to 35.5% due to cost-saving initiatives.
- European net sales decreased by 6% in USD and 2% in local currency.
- Canadian net sales fell by 10% in USD and 5% in local currency.
SHELTON, Conn., April 21, 2023 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) today announced that net sales for the quarter ended March 31, 2023 were
Net income was
Chairman and CEO Walter C. Johnsen said, “We are successfully executing our growth and productivity plans. Our net sales growth reflects expansion of our customer base and new product introductions in the first aid and medical segment, offset in part by continued inventory reductions by some large mass market customers. We realized over
Mr. Johnsen added, “The Company is on track to realize projected annual savings of
For the first quarter of 2023, net sales in the U.S. segment increased
European net sales for the first quarter of 2023 decreased
Net sales in Canada for the first quarter of 2023 decreased
Gross margin was
Operating income in the first quarter of 2023 increased
Interest expense in the first quarter of 2023 increased
The Company’s bank debt less cash on March 31, 2023 was
Conference Call and Webcast Information
Acme United will hold a conference call to discuss its quarterly results, which will be broadcast on Friday, April 21, 2023, at 12:00 p.m. ET. To listen or participate in a question and answer session, dial 877-407-0784 . International callers may dial 201-689-8560. The confirmation code is 13737289. You may access the live webcast of the conference call through the Investor Relations section of the Company’s website, www.acmeunited.com. A replay may be accessed under Investor Relations, Audio Archives.
About Acme United
ACME UNITED CORPORATION is a leading worldwide supplier of innovative safety solutions and cutting technology to the school, home, office, hardware, sporting goods and industrial markets. Its leading brands include First Aid Only®, First Aid Central®, PhysiciansCare®, Spill Magic®, Westcott®, Clauss®, Camillus®, Cuda®, DMT®, Med-Nap and Safety Made. For more information, visit www.acmeunited.com.
Forward Looking Statements
The Company may from time to time make written or oral “forward-looking statements” including statements contained in this report and in other communications by the Company, which are made in good faith pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on our beliefs as well as assumptions made by and information currently available to us. When used in this document, words like “may,” “might,” “will,” “except,” “anticipate,” “believe,” “potential,” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from our current expectations.
Forward-looking statements in this report, including without limitation, statements related to the Company’s plans, strategies, objectives, expectations, intentions and adequacy of resources, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties that may impact the Company’s business, operations and financial results, including those risks and uncertainties resulting from the global COVID-19 pandemic, future waves of COVID-19, including through the Delta and Omicron variants and any new variant strains of the underlying virus; any future pandemics; the continuing effectiveness, global availability, and public acceptance of existing vaccines; the effectiveness, availability, and public acceptance of vaccines against variant strains of potential new viruses; and the heightened impact the pandemic has on many of the risks described herein, including, without limitation, risks relating to disruptions in our supply chain, and labor shortages, any of which could materially adversely impact the Company’s ability to manufacture, source or distribute its products, both domestically and internationally.
These risks and uncertainties further include, without limitation, the following: (i) changes in the Company’s plans, strategies, objectives, expectations and intentions, which may be made at any time at the discretion of the Company; (ii) the impact of uncertainties in global economic conditions, whether caused by COVID-19 or otherwise, including the impact on the Company’s suppliers and customers; (iii) additional disruptions in the Company’s supply chains, whether caused by COVID-19, natural disasters or otherwise; (iv) labor-related costs the Company has incurred and continues to incur, including costs of acquiring and training new employees and rising wages and benefits; (v) the continuing adverse impact of inflation on products costs and interest rates; (vi) the Company’s ability to effectively manage its inventory in a rapidly changing business environment, including the additional inventory the Company acquired in anticipation of supply chain disruptions and uncertainties; (vii) potential adverse effects on the Company, its customers, and suppliers resulting from the war in Ukraine; (viii) changes in client needs and consumer spending habits; (ix) the impact of competition; (x) the impact of technological changes including, specifically, the growth of online marketing and sales activity; (xi) the Company’s ability to manage its growth effectively, including its ability to successfully integrate any business it might acquire; (xii) currency fluctuations; (xiii) international trade policies and their impact on demand for our products and our competitive position, including the imposition of new tariffs or changes in existing tariff rates; and (xiv) other risks and uncertainties indicated from time to time in the Company’s filings with the Securities and Exchange Commission.
ACME UNITED CORPORATION | |||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||||
FIRST QUARTER REPORT 2023 | |||||||||||
(Unaudited) | |||||||||||
Quarter Ended | Quarter Ended | ||||||||||
Amounts in 000's except per share data | March 31, 2023 | March 31, 2022 | |||||||||
Net sales | $ | 45,838 | $ | 43,333 | |||||||
Cost of goods sold | 29,557 | 28,365 | |||||||||
Gross profit | 16,281 | 14,968 | |||||||||
Selling, general and administrative expenses | 14,093 | 13,597 | |||||||||
Operating income | 2,188 | 1,371 | |||||||||
Interest expense | 919 | 309 | |||||||||
Interest income | (17 | ) | (4 | ) | |||||||
Net interest expense | 902 | 305 | |||||||||
Other income, net | (23 | ) | (2 | ) | |||||||
Income before income tax expense | 1,309 | 1,068 | |||||||||
Income tax expense | 319 | 238 | |||||||||
Net income | $ | 990 | $ | 830 | |||||||
Shares outstanding - basic | 3,541 | 3,521 | |||||||||
Shares outstanding - diluted | 3,541 | 3,848 | |||||||||
Earnings per share - basic | $ | 0.28 | $ | 0.24 | |||||||
Earnings per share - diluted | 0.28 | 0.22 | |||||||||
ACME UNITED CORPORATION | |||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||||||
FIRST QUARTER REPORT 2023 | |||||||||||
(Unaudited) | |||||||||||
Amounts in | |||||||||||
March 31, 2023 | March 31, 2022 | ||||||||||
Assets | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 2,764 | $ | 5,307 | |||||||
Accounts receivable, net | 32,972 | 34,605 | |||||||||
Inventories | 58,488 | 60,716 | |||||||||
Prepaid expenses and other current assets | 4,961 | 3,810 | |||||||||
Total current assets | 99,185 | 104,438 | |||||||||
Property, plant and equipment, net | 26,397 | 23,887 | |||||||||
Operating lease right of use asset | 2,675 | 3,064 | |||||||||
Intangible assets, less accumulated amortization | 20,272 | 16,888 | |||||||||
Goodwill | 8,189 | 4,800 | |||||||||
Other assets | 750 | - | |||||||||
Total assets | $ | 157,468 | $ | 153,077 | |||||||
Liabilities and stockholders' equity | |||||||||||
Current liabilities: | |||||||||||
Accounts payable | $ | 10,597 | $ | 10,939 | |||||||
Operating lease liability - short term | 1,216 | 1,112 | |||||||||
Mortgage payable - short term | 405 | 389 | |||||||||
Other current liabilities | 11,816 | 8,937 | |||||||||
Total current liabilities | 24,034 | 21,377 | |||||||||
Long-term debt | 40,135 | 40,151 | |||||||||
Mortgage payable - long term | 10,597 | 10,989 | |||||||||
Operating lease liability - long term | 1,628 | 2,187 | |||||||||
Other non-current liabilities | 957 | 600 | |||||||||
Total liabilities | 77,351 | 75,304 | |||||||||
Total stockholders' equity | 80,117 | 77,773 | |||||||||
Total liabilities and stockholders' equity | $ | 157,468 | $ | 153,077 | |||||||
CONTACT:
Paul G. Driscoll
Acme United Corporation
1 Waterview Drive
Shelton, CT 06484
Phone: (203) 254-6060
FAQ
What were Acme United's Q1 2023 net sales figures?
How much did Acme United's net income increase in Q1 2023?
What is the earnings per share (EPS) for Acme United in Q1 2023?